Profil
Robert J.
Schotzinger was the founder of Viamet Pharmaceuticals, Inc., founded in 2007, where the titles held included President & Chief Executive Officer from 2007 to 2014.
Current jobs include Chairman & Chief Executive Officer at Eldec Pharmaceuticals, Inc. starting in 2024; Director at Innocrin Pharmaceuticals Holdings LLC; Director at Innocrin Pharmaceuticals, Inc.; Director at Arrevus, Inc. since 2019; and Director at Propella Therapeutics, Inc. Former jobs include President & Chief Executive Officer at BioStratum, Inc., President, Chief Executive Officer & Director at Viamet Pharmaceuticals Corp., and Vice President-Drug Development at Abbott Laboratories.
Education includes a doctorate from Case Western Reserve University and an undergraduate degree from The Ohio State University.
Aktive Positionen von Robert Schotzinger
| Unternehmen | Position | Beginn |
|---|---|---|
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Direktor/Vorstandsmitglied | - |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer | Direktor/Vorstandsmitglied | - |
Propella Therapeutics, Inc.
Propella Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that has developed a platform that combines medicinal chemistry | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Schotzinger
| Unternehmen | Position | Ende |
|---|---|---|
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Direktor/Vorstandsmitglied | - |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Vorstandsvorsitzender | - |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Gründer | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Präsident | - |
Ausbildung von Robert Schotzinger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Health Technology |
Propella Therapeutics, Inc.
Propella Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that has developed a platform that combines medicinal chemistry | Health Technology |
















